Inicio › Colitis ulcerativa › Pensilvania
Ensayos clínicos de Colitis ulcerativa en Pensilvania
12 estudios sobre Colitis ulcerativa buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Michigan Center of Medical Research, Farmington Hill
- Frontier Clinical Research, Uniontown
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07577856A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- The Children's Hospital of Philadelphia /ID# 273222, Philadelphia
- Upmc Children'S Hospital Of Pittsburgh /ID# 272328, Pittsburgh
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07071519Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Allegheny Health, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 23 oct 2026 · NCT05987852An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Penn State Milton S. Hershey Medical Center - Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine - Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health - Site Number: 8400107, Pittsburgh
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07184996A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07185009A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06405087A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 7 oct 2026 · NCT04844606Inflammatory Bowel Disease (IBD) Research Registry
- University of Pittsburgh Medical Center, Pittsburgh
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT04243525BOOM-IBD2 Pivotal Clinical Trial
- Pennsylvania Hospital, Philadelphia
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06571669Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 abr 2026 · NCT07223424De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.